FILE:CAH/CAH-8K-20060711182231.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
 
Item 7.01 Regulation FD Disclosure
     On July 11, 2006, Cardinal Health, Inc. (the "Company") agreed to repurchase $395 million of its common shares in a private transaction with an unaffiliated third party. This share repurchase, which will be completed this week, is part of a new $500 million share repurchase program approved by the Company's Board of Directors on June 28, 2006. The Company completed the $500 million share repurchase program announced on April 27, 2006 during the fourth quarter of its fiscal year ended June 30, 2006.
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


